Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
October 2005
2005:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2006 | 2007 | 2008
News | News in brief | News Features
News
Trial aims to measure social effects of choosing babies' sex
US doctors have launched a clinical trial to assess the effects of allowing couples to select whether they will have a boy or a girl.
Nature (27 October 2005)
| Full Text |
Europe revamps visa rules to attract world's best minds
With the introduction of 'Scientist visas' the European Union aims to make it faster for non-EU researchers to get the visas they need.
Nature (27 October 2005)
| Full Text |
Cash interests taint drug advice
Nature exposes close ties between the researchers and physicians who write the rules on prescribing drugs and the pharmaceutical industry.
Nature (20 October 2005)
| Full Text |
Biologists forced to reassess embryo test
A technique for detecting genetic abnormalities in embryos is itself coming under the microscope.
Nature (20 October 2005)
| Full Text |
'Ethical' routes to stem cells highlight political divide
This week two novel methods for deriving stem cells without destroying viable embryos were revealed.
Nature (20 October 2005)
| Full Text |
Korea launches network to share cloning information
The World Stem Cell Hub, an international network for exchanging embryonic stem-cell lines and cloning technology, has been launched by the South Korean government.
Nature (20 October 2005)
| Full Text |
US progressives fight for a voice in bioethics
A left-leaning think-tank aims to influence political decisions on scientific and medical topics.
Nature (13 October 2005)
| Full Text |
Indonesia struggles to control bird flu outbreak
As officials in Washington discuss how to tackle bird flu more effectively, the outbreak in humans continues in Asia.
Nature (13 October 2005)
| Full Text |
Chemical exchange captures Nobel
This year's Nobel Prize in Chemistry has been won by three researchers who pioneered the understanding and use of metathesis, a very general class of reactions that aid the construction of carbon-based (organic) molecules.
Nature (13 October 2005)
| Full Text |
Ig Nobels hail world's longest-running experiment
Distinguished scientists gather in Boston for silliness awards.
Nature (13 October 2005)
| Full Text |
The 1918 flu virus is resurrected
The recreation of one of the deadliest diseases known could help us to prevent another pandemic. Or it might trigger one.
Nature (6 October 2005)
| Full Text |
Japan jumps towards personalized medicine
Desktop-device uses advanced DNA chip to analyze patient's blood.
Nature (6 October 2005)
| Full Text |
Electric current captures top sperm
Fertility researchers have devised a way to isolate high-quality sperm from a sample of semen using an electric current.
Nature (6 October 2005)
| Full Text |
California prepares to roll out stem-cell funding
The funds for California's stem-cell research initiative may soon be flowing despite legal challenges.
Nature (6 October 2005)
| Full Text |
Gut feeling secures medical Nobel for Australian doctors
Barry Marshall and Robin Warren have won this year's Nobel Prize in Medicine for discovering that most stomach ulcers are caused by the bacterium Helicobacter pylori.
Nature (6 October 2005)
| Full Text |
New IGF drug stirs competition in growth factor segment
The use of insulin-like growth factor 1 (IGF-1) to promote growth in a rare group of very small children has recently been approved in the US.
Nature Biotechnology (October 2005)
| Full Text |
Diabetes groups question whether 'metabolic syndrome' exists
The American Diabetes Association (ADA) and the European Association for the Study of Diabetes have published a joint paper which questions whether the term 'metabolic syndrome' counts as a syndrome at all.
Nature Medicine (October 2005)
| Full Text |
News in brief
Yale hit by discrimination row over Chinese graduate
| German researchers angry at plan to expand ministry
| Europe's nascent research council takes shape
| Darwin's body of work evolves into online archive
| Retractions trigger lawsuit over a damaged reputation
| Radical moves proposed to help US keep its global edge
| UK science panel targets evidence for policies
| US tightens rules in battle against mad cow disease
| Long-term child health study awaits funding
| Head of drugs watchdog drops some cancer duties
| Germany's prodigal sons tell it to buck up funding
| Pfizer continues to bulk up on antibody technology
| US public ambivalent
| US group cautions against breast cancer screening
| Genetic techniques garner Lasker Award
| Chimp DNA could decode human diseases
News Features
Neuroscience: While you were sleeping
The flailing limbs of someone acting out their dreams in bed is shedding fresh light on the development of neurodegenerative disorders.
Nature (27 October 2005)
| Full Text |
Exploring life's sweet spot
Like proteins and nucleic acids, carbohydrates have essential roles in the cell, but the tools to synthesize and analyze this third class of biopolymer have, until recently, lagged far behind.
Nature (27 October 2005)
| Full Text |
Human genome: Patchwork people
For years it was assumed that tiny differences in our genetic make-up gave us our individual traits. Now it seems that those characteristics are caused by rearrangements of large chunks of our DNA.
Nature (20 October 2005)
| Full Text |
Drug discovery: Playing dirty
Forget drugs carefully designed to hit one particular molecule — a better way of treating complex diseases such as cancer may be to aim for several targets at once.
Nature (13 October 2005)
| Full Text |
American Chemical Society: Chemical reaction
The friction that arises when a scientific society aims both to serve its members and stay commercially competitive is generating heat within the American Chemical Society.
Nature (6 October 2005)
| Full Text |
Fetal-cell therapy: Paper chase
Since 2001, the Chinese neurosurgeon Hongyun Huang has used cells from aborted fetuses to treat some 600 patients with a number of neurological problems, yet no Western journal editor seems willing to publish his research.
Nature (6 October 2005)
| Full Text |
Screen savers
Several states in the US are moving to screen newborns for 29 rare diseases. But are they serving the best interests of their citizens?
Nature Medicine (October 2005)
| Full Text |
|
